Erratum: Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree (International Journal of Neuropsychopharmacology (2011) DOI:10.1017/S1461145711001374);Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree

International Journal of Neuropsychopharmacology

Volumn 15, Issue 3, 2012, Pages 309-319

  Teltsh, Omri ^a   Kanyas Sarner, Kyra ^a   Rigbi, Amihai ^a   Greenbaum, Lior ^a   Lerer, Bernard ^a   Kohn, Yoav ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Association; AVP; chromosome 20; OXT; schizophrenia

Indexed keywords

ARGININE; OXYTOCIN; VASOPRESSIN; ATRN PROTEIN, HUMAN; AVP PROTEIN, HUMAN; MEMBRANE PROTEIN; NEUROPHYSIN; PANTOTHENATE KINASE; PHOSPHOTRANSFERASE; PROTEIN PRECURSOR; VASOPRESSIN DERIVATIVE;

ADULT; ARAB; ARTICLE; AVP GENE; BRAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE; GENE CLUSTER; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN TISSUE; ISRAEL; JEW; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NUCLEAR FAMILY; OXT GENE; PEDIGREE; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; BIPOLAR DISORDER; CASE CONTROL STUDY; COHORT ANALYSIS; FAMILY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ARABS; BIPOLAR DISORDER; BRAIN; CASE-CONTROL STUDIES; COHORT STUDIES; FAMILY; FEMALE; GENE EXPRESSION REGULATION; HAPLOTYPES; HUMANS; ISRAEL; JEWS; MALE; MEMBRANE PROTEINS; NEUROPHYSINS; OXYTOCIN; PEDIGREE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROTEIN PRECURSORS; SCHIZOPHRENIA; VASOPRESSINS;

EID: 84858794365     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145712001162     Document Type: Erratum

References (56)

1. Alkelai A, Kohn Y, Olender T, Sarner-Kanyas K, et al. (2009). Evidence for an interaction of schizophrenia susceptibility loci on chromosome 6q23.3 and 10q24.33-q26.13 in arab israeli families. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 150B, 914-925.
2. Alkelai A, Lupoli S, Greenbaum L, Kohn Y, et al. (in press). Identification of new schizophrenia susceptibility loci and in an ethnically homogeneous, arab israeli sample by family-based, genome wide association. FASEB.
3. Amann-Zalcenstein D, Avidan N, Kanyas K, Ebstein RP, et al. (2006). AHI1, a pivotal neurodevelopmental gene, and c6orf217 are associated with susceptibility to schizophrenia. European Journal of Human Genetics 14, 1111-1119. (Pubitemid 44463970)
4. APA (1994). Diagnostic Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association.
5. Bakharev VD, Tikhomirov SM, Lozhkina TK (1986). Psychotropic properties of oxytocin. Neuroscience and Behavioral Physiology 16, 160-164.
6. Baron M, Endicott J, Lerer B, Loth JE, et al. (1994). A pedigree series for mapping disease genes in bipolar affective disorder : sampling, assessment, and analytic considerations. Psychiatric Genetics 4, 43-55. (Pubitemid 24133300)
7. Barrett JC, Fry B, Maller J, Daly MJ (2005). Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265. (Pubitemid 40202029)
8. Brambilla F, Aguglia E, Massironi R, Maggioni M, et al. (1986). Neuropeptide therapies in chronic schizophrenia : TRH and vasopressin administration. Neuropsychobiology 15, 114-121. (Pubitemid 16002993)
9. Brambilla F, Bondiolotti GP, Maggioni M, Sciascia A, et al. (1989). Vasopressin (DDAVP) therapy in chronic schizophrenia : effects on negative symptoms and memory. Neuropsychobiology 20, 113-119.
10. Bujanow W (1972). Hormones in the treatment of psychoses. British Medical Journal 4, 298.
11. Caldwell HK, Lee HJ, Macbeth AH, Young III WS (2008). Vasopressin: behavioral roles of an 'original' neuropeptide. Progress in Neurobiology 84, 1-24.
12. Coulson JM (2002). Positive and negative regulators of the vasopressin gene promoter in small cell lung cancer. Progress in Brain Research 139, 329-343. (Pubitemid 35469058)
13. Couture SM, Penn DL, Roberts DL (2006). The functional significance of social cognition in schizophrenia : A review. Schizophrenia Bulletin 32 (Suppl. 1), S44-S63.
14. Craig JS, Hatton C, Craig FB, Bentall RP (2004). Persecutory beliefs, attributions and theory of mind: comparison of patients with paranoid delusions, asperger's syndrome and healthy controls. Schizophrenia Research 69, 29-33. (Pubitemid 38625756)
15. Curwen V, Eyras E, Andrews TD, Clarke L, et al. (2004). The ensemble automatic gene annotation system. Genome Research 14, 942-950. (Pubitemid 38660514)
16. Egashira N, Tanoue A, Higashihara F, Fuchigami H, et al. (2005). Disruption of the prepulse inhibition of the startle reflex in vasopressin v1b receptor knockout mice: reversal by antipsychotic drugs. Neuropsychopharmacology 30, 1996-2005. (Pubitemid 43093500)
17. Feifel D, Priebe K (2001). Vasopressin-deficient rats exhibit sensorimotor gating deficits that are reversed by subchronic haloperidol. Biological Psychiatry 50, 425-433. (Pubitemid 32885592)
18. Fields RL, House SB, Gainer H (2003). Regulatory domains in the intergenic region of the oxytocin and vasopressin genes that control their hypothalamus-specific expression in vitro. Journal of Neuroscience 23, 7801-7809. (Pubitemid 37052348)
19. Fishelson M, Geiger D (2002). Exact genetic linkage computations for general pedigrees. Bioinformatics 18 (Suppl. 1), S189-S198. (Pubitemid 41185653)
20. Gejman PV, Sanders AR, Duan J (2010). The role of genetics in the etiology of schizophrenia. Psychiatric Clinics of North America 33, 35-66.
21. Goldman M, Marlow-O'Connor M, Torres I, Carter CS (2008). Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits. Schizophrenia Research 98, 247-255. (Pubitemid 350235898)
22. Green EK, Grozeva D, Jones I, Jones L, et al. (2009). The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Molecular Psychiatry 15, 1016-1022.
23. Higgs BW, Elashoff M, Richman S, Barci B (2006). An online database for brain disease research. BMC Genomics 7, 70.
24. Hollander E, Bartz J, Chaplin W, Phillips A, et al. (2007). Oxytocin increases retention of social cognition in autism. Biological Psychiatry 61, 498-503. (Pubitemid 46185336)
25. Hollander E, Novotny S, Hanratty M, Yaffe R, et al. (2003). Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharmacology 28, 193-198.
26. Hughes C, Soares-Boucaud I, Hochmann J, Frith U (1997). Social behaviour in pervasive developmental disorders: effects of informant, group and 'theory-of-mind'. European Child and Adolescent Psychiatry 6, 191-198.
27. Insel TR, O'Brien DJ, Leckman JF (1999). Oxytocin, vasopressin, and autism: is there a connection? Biological Psychiatry 45, 145-157.
28. Jaber L, Halpern GJ, Shohat T (2000). Trends in the frequencies of consanguineous marriages in the israeli arab community. Clinical Genetics 58, 106-110.
29. Jacob S, Brune CW, Carter CS, Leventhal BL, et al. (2007). Association of the oxytocin receptor gene (OXTR) in caucasian children and adolescents with autism. Neuroscience Letters 417, 6-9. (Pubitemid 46517832)
30. Kent WJ, Sugnet CW, Furey TS, Roskin KM, et al. (2002). The human genome browser at UCSC. Genome Research 12, 996-1006. (Pubitemid 34662293)
31. Keri S, Kiss I, Kelemen O (2009). Sharing secrets : oxytocin and trust in schizophrenia. Social Neuroscience 4, 287-293.
32. Kim SJ, Young LJ, Gonen D, Veenstra-VanderWeele J, et al. (2002). Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism. Molecular Psychiatry 7, 503-507. (Pubitemid 34712902)
33. Klin A, Jones W, Schultz R, Volkmar F, et al. (2002). Visual fixation patterns during viewing of naturalistic social situations as predictors of social competence in individuals with autism. Archives of General Psychiatry 59, 809-816. (Pubitemid 35001146)
34. Lange C, DeMeo DL, Laird NM (2002). Power and design considerations for a general class of family-based association tests : quantitative traits. American Journal of Human Genetics 71, 1330-1341. (Pubitemid 36015888)
35. Lee HJ, Macbeth AH, Pagani JH, Young III WS (2009). Oxytocin: the great facilitator of life. Progress in Neurobiology 88, 127-151.
36. Legros JJ, Gazzotti C, Carvelli T, Franchimont P, et al. (1992). Apomorphine stimulation of vasopressin-and oxytocin-neurophysins. evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics. Psychoneuroendocrinology 17, 611-617. (Pubitemid 23043123)
37. Lerer B, Segman RH, Hamdan A, Kanyas K, et al. (2003). Genome scan of arab israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24. Molecular Psychiatry 8, 488-498. (Pubitemid 36829691)
38. Lerer E, Levi S, Salomon S, Darvasi A, et al. (2008). Association between the oxytocin receptor (OXTR) gene and autism: relationship to vineland adaptive behavior scales and cognition. Molecular Psychiatry 13, 980-988.
39. Levi A, Kohn Y, Kanyas K, Amann D, et al. (2005). Fine mapping of a schizophrenia susceptibility locus at chromosome 6q23: increased evidence for linkage and reduced linkage interval. European Journal of Human Genetics 13, 763-771. (Pubitemid 40846849)
40. Modahl C, Green L, Fein D, Morris M, et al. (1998). Plasma oxytocin levels in autistic children. Biological Psychiatry 43, 270-277. (Pubitemid 28085673)
41. Moskvina V, Craddock N, Holmans P, Nikolov I, et al. (2009). Gene-wide analyses of genome-wide association data sets : evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Molecular Psychiatry 14, 252-260.
42. O'Donovan MC, Craddock N, Norton N, Williams H, et al. (2008). Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nature Genetics 40, 1053-1055.
43. Pilowsky T, Yirmiya N, Arbelle S, Mozes T (2000). Theory of mind abilities of children with schizophrenia, children with autism, and normally developing children. Schizophrenia Research 42, 145-155. (Pubitemid 30163080)
44. Pinkham AE, Penn DL, Perkins DO, Lieberman J (2003). Implications for the neural basis of social cognition for the study of schizophrenia. American Journal of Psychiatry 160, 815-824. (Pubitemid 41079565)
45. Purcell SM, Wray NR, Stone JL, Visscher PM, et al. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752.
46. Sobel E, Lange K (1996). Descent graphs in pedigree analysis : Applications to haplotyping, location scores, and marker-sharing statistics. American Journal of Human Genetics 58, 1323-1337. (Pubitemid 26153844)
47. Souza RP, de Luca V, Meltzer HY, Lieberman JA, et al. (2010a). Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes. International Journal of Neuropsychopharmacology 13, 793-798.
48. Souza RP, Ismail P, Meltzer HY, Kennedy JL (2010b). Variants in the oxytocin gene and risk for schizophrenia. Schizophrenia Research 121, 279-280.
49. Spitzer RL, Endicott J, Robins E (1978). Research diagnostic criteria : rationale and reliability. Archives of General Psychiatry 35, 773-782. (Pubitemid 9064061)
50. Teltsh O, Kanyas K, Karni O, Levi A, et al. (2008). Genomewide linkage scan, fine mapping, and haplotype analysis in a large, inbred, arab israeli pedigree suggest a schizophrenia susceptibility locus on chromosome 20p13. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 147B, 209-215. (Pubitemid 351355282)
51. Wang CP, Lee YF, Chang C, Lee HJ (2006). Transactivation of the proximal promoter of human oxytocin gene by TR4 orphan receptor. Biochemical and Biophysical Research Communications 351, 204-208. (Pubitemid 44635427)
52. Wassink TH, Piven J, Vieland VJ, Pietila J, et al. (2004). Examination of AVPR1a as an autism susceptibility gene. Molecular Psychiatry 9, 968-972. (Pubitemid 39381961)
53. Wu S, Jia M, Ruan Y, Liu J, et al. (2005). Positive association of the oxytocin receptor gene (OXTR) with autism in the chinese han population. Biological Psychiatry 58, 74-77. (Pubitemid 40909939)
54. Yirmiya N, Rosenberg C, Levi S, Salomon S, et al. (2006). Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: mediation by socialization skills. Molecular Psychiatry 11, 488-494.
55. Ylisaukko-oja T, Alarcon M, Cantor RM, Auranen M, et al. (2006). Search for autism loci by combined analysis of autism genetic resource exchange and finnish families. Annals of Neurology 59, 145-155. (Pubitemid 43042881)
56. Yrigollen CM, Han SS, Kochetkova A, Babitz T, et al. (2008). Genes controlling affiliative behavior as candidate genes for autism. Biological Psychiatry 63, 911-916.